- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Aging Research
Volume 2011 (2011), Article ID 383091, 4 pages
CLOCK Genes and Circadian Rhythmicity in Alzheimer Disease
1Department of Psychiatry, University of Rostock, Gehlsheimerstraße 20, 18147 Rostock, Germany
2Department of Psychology, National University of Ireland, Maynooth, Maynooth, Ireland
3Biochemistry and Proteomics Group, Department of Chemistry and Biomolecular Science, Clarkson University, Potsdam, NY 13699, USA
4Department of Child and Adolescent Psychiatry and Neurology, University of Rostock, 18147 Rostock, Germany
Received 2 August 2011; Accepted 16 August 2011
Academic Editor: Aurel Popa-Wagner
Copyright © 2011 J. Thome et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- D. E. Barnes and K. Yaffe, “The projected effect of risk factor reduction on Alzheimer's disease prevalence,” The Lancet Neurology, vol. 10, no. 9, pp. 819–828, 2011.
- A. Alzheimer, “Über eine eigenartige Erkrankung der Hirnrinde,” Allgemeine Zeitschrift für Psychiatrie und psychisch-gerichtliche Medizin, vol. 64, pp. 146–148, 1907.
- K. Bettens, K. Sleegers, and C. van Broeckhoven, “Current status on alzheimer disease molecular genetics: from past, to present, to future,” Human Molecular Genetics, vol. 19, no. 1, Article ID ddq142, pp. R4–R11, 2010.
- W. Retz, J. Thome, N. Durany et al., “Potential genetic markers of sporadic Alzheimer's dementia,” Psychiatric Genetics, vol. 11, no. 3, pp. 115–122, 2001.
- A. Rahmadi, N Steiner, and G. Münch, “Advanced glycation enproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease,” Clinical Chemistry and Laboratory Medicine, vol. 49, pp. 385–391, 2011.
- J. Thome, M. Rösler, M. John, N. Sakai, P. Riederer, and G. Muench, “Advanced glycatopn endproduct (AGE) inhibition as possible pharmacotherapeutic strategy in the treatmentof Alzheimer's dementia,” Drugs of the Future, vol. 24, no. 4, pp. 411–416, , pp. , 1999.
- B. A. Yankner and T. Lu, “Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease,” Journal of Biological Chemistry, vol. 284, no. 8, pp. 4755–4759, 2009.
- K. Iqbal and I. Grundke-Iqbal, “Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention,” Journal of Cellular and Molecular Medicine, vol. 12, no. 1, pp. 38–55, 2008.
- B. van Broeck, C. van Broeckhoven, and S. Kumar-Singh, “Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches,” Neurodegenerative Diseases, vol. 4, no. 5, pp. 349–365, 2007.
- V. O. Emery, “Alzheimer disease: are we intervening too late?” Journal of Neural Transmission, vol. 118, no. 9, pp. 1361–1378, 2011.
- D. G. Harper, E. G. Stopa, A. C. McKee, A. Satlin, D. Fish, and L. Volicer, “Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease,” Neurobiology of Aging, vol. 25, no. 6, pp. 771–781, 2004.
- D. G. Harper, E. G. Stopa, A. C. McKee et al., “Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration,” Archives of General Psychiatry, vol. 58, no. 4, pp. 353–360, 2001.
- D. G. Harper, L. Volicer, E. G. Stopa, A. C. McKee, M. Nitta, and A. Satlin, “Disturbance of endogenous circadian rhythm in aging and Alzheimer disease,” American Journal of Geriatric Psychiatry, vol. 13, no. 5, pp. 359–368, 2005.
- J. A. Yesavage, A. Noda, B. Hernandez et al., “Circadian clock gene polymorphisms and sleep-wake disturbance in Alzheimer disease,” American Journal of Geriatric Psychiatry, vol. 19, no. 7, pp. 635–643, 2011.
- A. N. Coogan and J. Thome, “Chronotherapeutics and psychiatry: setting the clock to relieve the symptoms,” World Journal of Biological Psychiatry, vol. 12, supplement 1, pp. 40–43, 2011.
- P. Franken and D. J. Dijk, “Circadian clock genes and sleep homeostasis,” European Journal of Neuroscience, vol. 29, no. 9, pp. 1820–1829, 2009.
- A. N. Coogan, M. M. Papachatzaki, C. Clemens, et al., “Haloperidol alters circadian clock gene product expression in the mouse brain,” World Journal of Biological Psychiatry. In press.
- K. Wulff, S. Gatti, J. G. Wettstein, and R. G. Foster, “Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease,” Nature Reviews Neuroscience, vol. 11, no. 8, pp. 589–599, 2010.
- D. L. Bliwise, N. D. Mercaldo, A. Y. Avidan, B. F. Boeve, S. A. Greer, and W. A. Kukull, “Sleep disturbance in dementia with Lewy bodies and Alzheimer's disease: amulticenter analysis,” Dementia and Geriatric Cognitive Disorders, vol. 31, no. 3, pp. 239–246, 2011.
- Y. Song, G. A. Dowling, M. I. Wallhagen, K. A. Lee, and W. J. Strawbridge, “Sleep in older adults with Alzheimer's disease,” Journal of Neuroscience Nursing, vol. 42, no. 4, pp. 190–198, 2010.
- E. Mulin, J. M. Zeitzer, L. Friedman et al., “Relationship between apathy and sleep disturbance in mild and moderate Alzheimer's disease: an actigraphic study,” Journal of Alzheimer's Disease, vol. 25, no. 1, pp. 85–91, 2011.
- J. Creese, M. Bédard, K. Brazil, and L. Chambers, “Sleep disturbances in spousal caregivers of individuals with Alzheimer's disease,” International Psychogeriatrics, vol. 20, no. 1, pp. 149–161, 2008.
- C. F. Hatfield, J. Herbert, E. J. W. van Someren, J. R. Hodges, and M. H. Hastings, “Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia,” Brain, vol. 127, no. 5, pp. 1061–1074, 2004.
- K. Hu, E. J. W. van Someren, S. A. Shea, and F. A. J. L. Scheer, “Reduction of scale invariance of activity fluctuations with aging and Alzheimer's disease: involvement of the circadian pacemaker,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 8, pp. 2490–2494, 2009.
- E. G. Stopa, L. Volicer, V. Kuo-Leblanc et al., “Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia,” Journal of Neuropathology and Experimental Neurology, vol. 58, no. 1, pp. 29–39, 1999.
- J. N. Zhou, M. A. Hofman, and D. F. Swaab, “VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease,” Neurobiology of Aging, vol. 16, no. 4, pp. 571–576, 1995.
- D. Bachman and P. Rabins, “‘Sundowning’ and other temporally associated agitation states in dementia patients,” Annual Review of Medicine, vol. 57, pp. 499–511, 2006.
- B. Tate, K. S. Aboody-Guterman, A. M. Morris, E. C. Walcott, R. E. Majocha, and C. A. Marotta, “Disruption of circadian regulation by brain grafts that overexpress Alzheimer beta/A4 amyloid,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 15, pp. 7090–7094, 1992.
- R. Sterniczuk, R. H. Dyck, F. M. Laferla, and M. C. Antle, “Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes,” Brain Research, vol. 1348, pp. 139–148, 2010.
- A. W. Bero, P. Yan, J. H. Roh, et al., “Neuronal activity regulates the regional vulnerability to amyloid-b deposition,” Nature Neuroscience, vol. 14, pp. 750–756, 2011.
- D. Craig, D. J. Hart, and A. P. Passmore, “Genetically increased risk of sleep disruption in Alzheimer's disease,” Sleep, vol. 29, no. 8, pp. 1003–1007, 2006.
- C. Kissling, W. Retz, S. Wiemann et al., “A polymorphism at the -untranslated region of the CLOCK gene is associated with adult attention-deficit hyperactivity disorder,” American Journal of Medical Genetics Part B, vol. 147, no. 3, pp. 333–338, 2008.
- N. Cermakian, E. W. Lamont, P. Boudreau, and D. B. Boivin, “Circadian clock gene expression in brain regions of Alzheimer's disease patients and control subjects,” Journal of Biological Rhythms, vol. 26, no. 2, pp. 160–170, 2011.
- A. L. Beynon, J. Thome, and A. N. Coogan, “Age and time of day influences on the expression of transforming growth factor-beta and phosphorylated SMAD3 in the mouse suprachiasmatic and paraventricular nuclei,” NeuroImmunoModulation, vol. 16, no. 6, pp. 392–399, 2009.
- R. Y. Liu, J. N. Zhou, W. J. G. Hoogendijk et al., “Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression,” Journal of Neuropathology and Experimental Neurology, vol. 59, no. 4, pp. 314–322, 2000.
- A. M. Rosenwasser, “Circadian clock genes: non-circadian roles in sleep, addiction, and psychiatric disorders?” Neuroscience and Biobehavioral Reviews, vol. 34, no. 8, pp. 1249–1255, 2010.
- E. I. S. Most, P. Scheltens, and E. J. W. van Someren, “Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light—a randomized clinical trial,” Trials, vol. 11, article 19, 2010.
- R. F. Riemersma-van der Lek, D. F. Swaab, J. Twisk, E. M. Hol, W. J. G. Hoogendijk, and E. J. W. Van Someren, “Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial,” JAMA—Journal of the American Medical Association, vol. 299, no. 22, pp. 2642–2655, 2008.
- A. Wirz-Justice, E. Werth, E. Savaskan, V. Knoblauch, P. F. Gasio, and F. Müller-Spahn, “Haloperidol disrupts, clozapine reinstates the circadian rest-activity cycle in a patient with early-onset Alzheimer disease,” Alzheimer Disease and Associated Disorders, vol. 14, no. 4, pp. 212–215, 2000.